Note: Ingredients listed on restricted chemical lists
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
≥10
EC/CAS
423-340-5/162881-26-7
Name of the chemical
Phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide
Concentration
≥2.5
EC/CAS
239-701-3/15625-89-5
Name of the chemical
2-ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3-propanediyl diacrylate; 2,2-bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate
Concentration
<2.5
EC/CAS
215-691-6/1344-28-1
Name of the chemical
aluminium oxide
Concentration
≥0.1
General Information
Version
9.0
Revision date
2023-05-31
Product name
Saphira Digital - Ink White Labelfire UV02
1.2.2. Uses advised against
Consumer uses: Private households (= general public = consumers)
Manufacturer Name
Heidelberger Druckmaschinen AG
Emergency telephone
+49 (0) 551 19240
Icons in SDS
Company Information
company name
Heidelberger Druckmaschinen AG
e-mail address of the competent person responsible for the Safety Data Sheet
hei.msds@heidelberg.com, ukinfo@heidelberg.com, hei.msds@heidelberg.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H318, H351, H411
Hazard statements
Code
Statements
H315
Causes skin irritation
H317
May cause an allergic skin reaction
H318
Causes serious eye damage.
H351
Suspected of causing cancer
H411
Toxic to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP)]
Adverse physicochemical, human health and environmental effects
Suspected of causing cancer. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye damage. Toxic to aquatic life with long lasting effects.
2.2 Label elements
Labelling
Hazard pictograms
GHS05 GHS07 GHS08 GHS09
Signal word
Danger
Contains
Methyl benzoylformate; ethoxylated trimethylolpropanetriacrylate; 3-Methyl-1,5- pentandiyldiacrylat; 2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien- 1-one; Poly[oxy(methyl-1,2-ethanediyl)], .alpha.,.alpha.',.alpha.''-1,2,3- propanetriyltris[.omega.-[(1-oxo-2-propenyl)oxy]]-; Esterification product of poly[oxy(methyl- 1,2-ethanediyl)], .alpha.,.alpha.'-(2,2-dimethyl-1,3-propanediyl)bis[.omega.-hydroxy- and prop-2-enoic acid; phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide; oxybis(methyl-2,1- ethanediyl) diacrylate; (5-ethyl-1,3-dioxan-5-yl)methyl acrylate; trimethylolpropane triacrylate
Hazard statements
H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H318 - Causes serious eye damage. H351 - Suspected of causing cancer. H411 - Toxic to aquatic life with long lasting effects.
Precautionary statements
P202 - Do not handle until all safety precautions have been read and understood. P261 - Avoid breathing spray, mist, vapours. P280 - Wear eye protection, protective gloves, protective clothing. P305+P351+P338+P310 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER, a doctor. P308+P313 - IF exposed or concerned: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %